Jobs
View more job listings or post a job
Bioduro-Sundia Associate Director/Director in Laboratory Animal and Exploratory Toxicology
Variant Bio (Senior) Scientist - DMPK
Alturas Analytics Scientist 1
University of California, Davis TOXICOLOGY ANALYTICAL CHEMIST (STAFF RESEARCH ASSOCIATE 3)
University of California, Davis CALIFORNIA ANIMAL HEALTH AND FOOD SAFETY LABORATORY - TOXICOLOGY LAB RESEARCH SUPERVISOR/GROUP LEADER
Eli Lilly and Company R-39973 Scientific Director ADME - Novel Modalities (Open)
FibroGen Director DMPK
Applied BioMath Technical Marketing Specialist
Horizon Therapeutics Director, Bioanalytical Sciences
Exelixis Principal Scientist - DMPK
Post a job

Symposium

[Free Online Symposium] Gene Therapy: Discovery, Development and Regulatory Perspectives


Speakers: Mark Milton (ex Novartis), Dhaval Shah (SUNY Buffalo), Brian Long (Biomarin), Abigail Johnson (FDA), Emmanuel Gyamfi (FDA)
Organizers: Shradda Sadekar (Genentech), Nagendra Chemuturi (Moderna), Dale Miles (Genentech), Snow Ge (BridgeBio)
Date: 2022-12-07- 12/7/2022
Time: 8:30-12:30 Pacific Time
Registration fee: 0
Location: Online via Zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2022-12-04  (it will close sooner if the seating cap is reached)

About the Topic

Objectives of the Symposium: 

- Gain an understanding of the different MOAs and durable pharmacology enabled by gene therapy, state of the field, and future outlook

- Appreciate unique challenges to gene delivery, PKPD translation, immunogenicity management, safety, and manufacturing of gene therapies

- Gain regulatory and preclinical and clinical development perspectives for effective bench-bedside development of gene therapies

 

Time (PST)

Time (EST)

Topic

Presenter

Moderator

8:30 - 8:35 am

11:30 - 11:35 am

PBSS Introduction/Welcome Remarks

Snow Ge, BridgeBio

Enas Mahmoud (PBSS)

8:35 - 8:40 am

11:35 - 11:40 am

Symposium Introduction

Shradda Sadekar, Genentech

Snow Ge (BridgeBio)

8:40 - 9:20 am

11:40 - 12:20 pm

In vivo AAV-based gene therapy- a brief primer

Mark Milton, PhD, Principal, Lake Boon Pharmaceutical Consulting, LLC

Shradda Sadekar (Genentech)

9:20 - 10:00 am

12:20 - 1:00 pm

Towards Development of a Platform PBPK Model for AAV Mediated Delivery of MAb Genes

Dhaval Shah, Associate Professor, PhD, MS, B.Pharm., SUNY Buffalo

Shradda Sadekar (Genentech)

10:00 - 10:40 am

1:00 - 1:40 pm

Immunogenicity Monitoring for AAV-Based Gene Therapies

Brian Long, PhD, Principal Scientist, Clinical Immunology at BioMarin Pharmaceutical Inc.

Shradda Sadekar (Genentech)

10:40 - 10:50 am

1:40 - 1:50 pm

QA Round 1 (Mark Milton, Dhaval Shah, Brian Long)

Shradda Sadekar (Genentech)

10:50 - 11:00 am

1:50 - 2:00 pm

Break

Dale Miles (Genentech)

11:00 - 11:40 am

2:00 - 2:40 pm

Gene Therapy Products in Oncology: Clinical and Regulatory Perspective

Abigail Johnson, RN, BSN, Clinical Reviewer/Analyst, FDA

Dale Miles (Genentech)

11:40 -12:20 pm

2:40 - 3:20 pm

Gene Therapy Product Chemistry, Manufacturing and Controls: Regulatory Perspective

Emmanuel Adu-Gyamfi, PhD, CMC Reviewer (Gene and Cell Therapy), FDA

Dale Miles (Genentech)

12:20 -12:30 pm

3:20 - 3:30 pm

QA Round 2 (Abigail Johnson, Emmanuel Adu-Gyamfi)

Dale Miles (Genentech)

Note: This is an online meeting, The Zoom link will be sent to the registrants 1+ days before the event.


2024-04-12, [Free Online] Innovative Life Science Technologies in the Drug Development Toolbox: From Cancer Organoids and Biomarker Profiling to Label-Free Multiplex QES Assays
2024-04-26, [In-Person] Oncology Clinical Dose Optimization in Light of FDA Project Optimus
2024-05-06, [In-Person] Human Mass Balance and Metabolite Profiling Studies: Strategies, Technical Approaches, Regulatory Guidance, Applications and Case Studies
2024-05-13, [Free Online] Highlights of 2023 FDA Drug Approvals
2024-05-21, [In-Person] Nonclinical Safety Studies for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices
2024-05-30, [Online Workshop] Career Transition for Research Scientists
2024-06-13, [In-Person] CMC Strategies and Activities for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices
2024-06-20, Alzheimer's Disease: untangling what we thought we knew and future Precision Medicine Diagnostics and Therapeutics
2024-09-10, [In-Person] Rethinking Translational PK/PD and Human Dose Projections for Novel Therapeutic Modalities: Covalent Inhibitors, PROTACs, Molecular Glues, ADCs, Ocular and Neuro delivery, Vaccines, Bispecifics, Cell and Gene Therapies
2024-09-20, [In-Person] Non-clinical safety assessments of biologics and novel modalities for IND/NDA Filing: Nuts, Bolts and Best Practices
2024-10-10, [In-Person] Regulatory Global Submission: Strategies and Best Practices for FDA, EMA and PMDA
©Pharmaceutical & BioScience Society, International; Last Modified: 3/28/2024; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Alturas Analytics, Inc. Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
Lena Biosciences Predictive toxicology. Mitochondrial toxicity in a drug metabolism-competent model with active transporters. Intrinsic & idiosyncratic DILI.
Submit a Text Ad